ClearPoint Neuro, Inc. (CLPT)

ClearPoint Neuro Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	399	424	167	208	265	268
Market Cap Growth	153.78%	153.78%	-19.62%	-21.59%	-1.05%	267.26%
Enterprise Value	382	406	157	179	228	271
Last Close Price	14.25	15.38	6.79	8.47	11.22	15.89
PS Ratio	12.27	13.52	6.98	10.12	16.27	20.90
PB Ratio	15.50	16.71	7.90	5.64	5.44	112.77
P/TBV Ratio	16.01	17.04	8.30	5.80	5.47	132.44
EV/Sales Ratio	12.17	12.95	6.55	8.73	13.97	21.16
Debt / Equity Ratio	0.14	0.14	0.66	0.33	0.25	10.15
Asset Turnover	0.77	0.77	0.49	0.34	0.34	0.62
Inventory Turnover	1.66	1.66	1.20	0.99	1.27	1.15
Quick Ratio	2.46	2.46	3.65	5.92	11.88	6.87
Current Ratio	3.22	3.22	4.87	7.54	13.02	7.96
Return on Equity (ROE)	-81.24%	-81.24%	-76.09%	-38.37%	-56.33%	-194.80%
Return on Assets (ROA)	-30.16%	-30.16%	-28.59%	-16.86%	-17.58%	-18.76%
Return on Capital (ROIC)	-38.52%	-38.52%	-33.41%	-18.57%	-19.09%	-23.18%
Earnings Yield	-4.74%	-4.46%	-13.21%	-7.90%	-5.43%	-2.53%
FCF Yield	-2.31%	-2.17%	-8.64%	-7.90%	-4.85%	-2.93%
Buyback Yield / Dilution	-9.85%	-9.84%	-1.75%	-16.63%	-30.82%	-20.48%

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q